Skip to main content
Clinical Trials/NL-OMON35021
NL-OMON35021
Not Yet Recruiting
N/A

Exhaled Breath profiling by an Electronic Nose in the Diagnosis of Pulmonary Sarcoidose - eNose and Pulmonary Sarcoidosis

Academisch Medisch Centrum0 sites120 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lung sarcoidosis
Sponsor
Academisch Medisch Centrum
Enrollment
120
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \* Adult patients, between 18\-70 years old, with a confirmed diagnosis of sarcoidosis. (Diagnosis of sarcoidosis according to the generally accepted consensus criteria.)
  • \* Treatment naïve patients. A low dose oral prednisolone (\< 10 mg daily) will be allowed.

Exclusion Criteria

  • \* Patients with underlying conditions with an established effect on the exhaled VOCs.
  • \* Any other respiratory disease except sarcoidosis and/or any systemic diseases.
  • \* Respiratory tract infections requiring antibiotics and/or oral steroids in the 4 weeks prior to the study will be excluded.
  • \* Current and ex tobacco Smoking. (However, patients with a smoking history of \< 1 packyear and no smoking during the past 10 years can be included).
  • \* Prior diagnosis of malignancies

Outcomes

Primary Outcomes

Not specified

Similar Trials